Szostak Michael J MD is categorized under Internal Medicine Doctors in New Port Richey, FL and active since 2010.
Szostak Michael J MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Michael Szostak at the company’s single location by writing to 2102 Trinity Oaks Boulevard, New Port Richey, Florida FL 34655 or by phoning (727) 376-4555. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Szostak Michael J MD |
| Contact Person: | Michael Szostak |
| Address: | 2102 Trinity Oaks Boulevard, New Port Richey, Florida 34655 |
| Phone Number: | (727) 376-4555 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Szostak Michael J MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Michael Szostak for inquiries that concern Szostak Michael J MD by calling the company number (727) 376-4555, as your correspondence is most welcome. Additionally, the physical location of the single location of Szostak Michael J MD can be found at the coordinates 28.18716,-82.677383 as well as the street address 2102 Trinity Oaks Boulevard in New Port Richey, Florida 34655.
For its online presence, you may visit Szostak Michael J MD’s website at and engage with its social media outlets through on Twitter and on Facebook.